Dogwood Therapeutics News

Dogwood Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8 21:19

Dogwood Therapeutics | 8-K: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

Nov 7 20:18

Dogwood Therapeutics | 8-K: Current report

Oct 30 21:27

3: Initial statement of beneficial ownership of securities-10% Owner Sealbond Ltd

Oct 18 04:33

3: Initial statement of beneficial ownership of securities-Director Yu Ying Choi Alan Abel

Oct 18 04:32

3: Initial statement of beneficial ownership of securities-Director Toh Kean Meng Melvin

Oct 18 04:31

SC 13D: Statement of acquisition of beneficial ownership by individuals-Sealbond Limited(15.9%),CK Life Sciences Int’l., (Holdings) Inc.(15.9%)

Oct 16 04:25

Virios Therapeutics | DEFA14A: Others

Oct 7 20:08

Virios Therapeutics | 8-K: Current report

Oct 7 20:03

Virios Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 22:17

Virios Therapeutics | 8-K: Virios Therapeutics Announces Second Quarter 2024 Financial Results

Aug 8 21:34

Virios Therapeutics | 8-K: Current report

Jun 20 21:17

Virios Therapeutics | 8-K: Current report

Jun 12 21:16

Virios Therapeutics | 424B4: Prospectus

May 21 04:14

Virios Therapeutics | 8-K: Current report

May 20 21:30

Virios Therapeutics | 424B4: Prospectus

May 18 04:04

Virios Therapeutics | 10-Q: Q1 2024 Earnings Report

May 10 22:34

Virios Therapeutics | 8-K: Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 9 20:02

Virios Therapeutics | 8-K: Current report

May 8 05:31

Virios Therapeutics | ARS: Annual Report to Security Holders

Apr 30 05:31